| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | M01AX17 |
| UNII: | V4TKW1454M |
| InChI Key | HYWYRSMBCFDLJT-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C13H12N2O5S |
| Molecular Weight | 308.31 |
| AlogP | 2.76 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 98.54 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Primary Target | |
|---|---|
| COX-1 | |
| COX-2 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 19
Cytochrome P450 family 19A
Cytochrome P450 19A1
|
- | 27000 | - | - | - | |
|
Enzyme
Hydrolase
|
- | - | - | 70000 | - | |
|
Enzyme
Oxidoreductase
|
- | 15-23140 | - | - | 7-100 | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4B
|
- | - | - | - | 52 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 58 | |
|
Transporter
Primary active transporter
Oxidoreduction-driven transporters
|
- | - | - | - | 90-90 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Pain | 1 | D010146 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 51803-78-2 |
| ChEBI | 44445 |
| ChEMBL | CHEMBL56367 |
| DrugBank | DB04743 |
| DrugCentral | 1935 |
| EPA CompTox | DTXSID3037250 |
| FDA SRS | V4TKW1454M |
| Guide to Pharmacology | 7401 |
| PDB | NIM |
| PharmGKB | PA137179528 |
| PubChem | 4495 |
| SureChEMBL | SCHEMBL24882 |
| ZINC | ZINC000004617749 |